Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) shares passed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $0.67 and traded as high as $0.9750. Eagle Pharmaceuticals shares last traded at $0.95, with a volume of 7,253 shares changing hands.
Eagle Pharmaceuticals Stock Performance
The company has a market capitalization of $12.60 million, a P/E ratio of 0.82 and a beta of 0.83. The company has a 50-day simple moving average of $0.68 and a 200 day simple moving average of $0.53.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc is a specialty pharmaceutical company focused on developing, manufacturing and commercializing injectable products for use in hospital and other acute-care settings. The company’s portfolio includes branded products, ready-to-use formulations and therapies designed to address clinical or logistical challenges associated with existing medicines.
Eagle’s marketed products have included Ryanodex (dantrolene sodium), an emergency treatment for malignant hyperthermia; Belrapzo (bendamustine hydrochloride), used in certain blood cancers; Pemfexy (pemetrexed), a chemotherapy treatment; Barhemsys (amisulpride), used to prevent and treat postoperative nausea and vomiting; and Byfavo (remimazolam), an intravenous sedative used for procedural sedation.
Further Reading
- Five stocks we like better than Eagle Pharmaceuticals
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
